CClinicalTrials.gg
CompletedNCT03462186Updated Jan 28, 2020

Promoting Patient Engagement in Clinical Preventive Services: Evaluating the Use of Healthfinder

An interventional study of Healthfinder invitation in Health Knowledge, Attitudes, Practice, sponsored by Virginia Commonwealth University. Completed at 1 site in United States. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-01-28.

Sponsored by Virginia Commonwealth University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
1,092
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Clinical preventive services (CPS) are fundamental to early disease detection and improvement of health outcomes but are often poorly understood and utilized by patients. Myhealthfinder is a web-based tool developed by the Office of Disease Prevention and Health Promotion (https://healthfinder.gov). This study tests the "prescription" of myhealthfinder to engage patients in CPS, improve patient-clinician communication and increase uptake of CPS.

02

Conditions studied

  • Health Knowledge, Attitudes, Practice
03

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Scheduled wellness appointment with primary care provider

Exclusion criteria

Exclusion Criteria:

  • Inability to read English
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
1,092 participants (actual)

Study arms

  • Experimental
    Intervention

    Invitation to use healthfinder website

    Other: Healthfinder invitation

  • No intervention
    Control

    No intervention

Interventions

  • OtherHealthfinder invitation

    Invitation to use healthfinder (healthfinder.gov/myhealthfinder

05

What researchers measure

Primary outcomes

  1. Uptake of clinical preventive services

    Percent up-to-datedness on cancer screening (cervical, breast, colon, lung cancer); immunizations (influenza, pneumonia) and cardiovascular disease (hypercholesterolemia, diabetes). This will be calculated based on the number of recommended services as identified on the healthfinder website based on age/gender that each patient has received within the recommended time frame.

    Time frame: 3 months

  2. Change in communication and health knowledge

    Patient survey asking about knowledge of recommended preventive services and communication with clinician; qualitative themes from audio-recordings of clinician-patient visit with subset of randomly selected patients

    Time frame: Immediately after the intervention

06

Study locations

1 site
  • Virginia Commonwealth University
    Richmond, Virginia 23298, United States
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03462186
Lead sponsor
Virginia Commonwealth University
Responsible party
Sponsor
First posted
Mar 12, 2018
Start date
Apr 15, 2018
Primary completion
Mar 30, 2019
Completion
Aug 14, 2019
Last update
Jan 28, 2020

Study contacts

Sebastian Tong, MD
principal investigator · Virginia Commonwealth University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion